3-O-acetylrubiarbonol B preferentially targets EGFR and MET over rubiarbonol B to inhibit NSCLC cell growth - A-Young Nam; Sang Hoon Joo; Na Yeong Lee; Goo Yoon; Jin Woo Park; MinKyun Na; Jung-Hyun Shim (PLoS ONE, 2025)